PMDA drug package insert
カルデナリン錠0.5mg
PMDA Prescription drug · ヴィアトリス製薬合同会社 · package insert Feb 27, 2026
Key facts
| Brand names | カルデナリン錠0.5mg, カルデナリン錠1mg, カルデナリン錠2mg, カルデナリン錠4mg, カルデナリンOD錠0.5mg, カルデナリンOD錠1mg, カルデナリンOD錠2mg, カルデナリンOD錠4mg |
|---|---|
| Nonproprietary names | ドキサゾシンメシル酸塩 |
| Companies | 製造販売元／ヴィアトリス製薬合同会社 |
| Product type | Prescription drug |
| Therapeutic category | 血圧降下剤 |
| Therapeutic category codes | 872149 |
| YJ codes | 2149026F1026, 2149026F2022, 2149026F3029, 2149026F4025, 2149026F5021, 2149026F6028, 2149026F7024, 2149026F8020 |
| Approval numbers | 20200AMZ00091, 20200AMZ00092, 20200AMZ00093, 20200AMZ00094, 22500AMX01528, 22500AMX01529, 22500AMX01530, 22500AMX01531 |
| Package insert edition | 第4版 |
| Package insert date | Feb 27, 2026 |
| PMDA document key | 671450_2149026F1026_4 |
| PMDA company code | 671450 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: